The Alliance for Regenerative Medicine (ARM) is the leading international advocacy organization championing the benefits of engineered cell therapies and genetic medicines for patients, healthcare systems, and society.
As a trusted source of expert perspectives, policy and regulatory insights, and industry data, ARM welcomes inquiries from journalists and media outlets covering developments in cell and gene therapy.
For media inquiries, please reach out to Stephen Majors at [email protected].
View ARM’s latest press releases and statements on major developments in the cell and gene therapy sector.
Access ARM’s quarterly data that highlights sector trends in clinical trials, investment, and developers.
ARM’s events convene cell and gene therapy industry executives and thought-leaders. Most events offer press passes at no cost.
Sign up for ARM’s weekly newsletter on sector news and alerts for events, reports, and other engagement opportunities.
